By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • The Wire
  • Health Topics
  • Podcast & Media
    • GMJ Audio
    • GMJ Videos
    • Podcast & Media
    • Podcast Episodes
  • GMJ Articles
    • Vol. 1 Issue 3 (2026)
    • Public Health Dictionary — Supplement Edition
    • IAP Legacy Series
    • Read Full Journal (gmj.ge) →
    • Pre-Launch Articles (2025)
    • Vol. 1 Issue 1 (2026)
    • Vol. 1 Issue 2 (2026)
  • Perspectives
    • Editorial
    • Explainers
    • Letters
    • Voices
  • Policy & Systems
    • Global Health
    • Health Policy
    • Migration & Health
    • Quality & Safety
    • Work & Health
  • Dictionary
    • Our Story: 20 Years in the Making
    • Browse A–Z
    • About the Project
    • Contribute a Term
  • Practice
    • Case Discussions
    • Clinical Updates
    • Pharmacy & Prescribing
  • Research Digest
    • Data & Numbers
    • Georgian Research
    • New Studies
  • Read the Journal →
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
  • The Wire
  • Health Topics
  • Podcast & Media
  • GMJ Articles
  • Perspectives
  • Policy & Systems
  • Dictionary
  • Practice
  • Research Digest
  • Read the Journal →
  • Latest News
    • GMJ Briefs
  • The Wire
  • Health Topics
  • Podcast & Media
    • GMJ Audio
    • GMJ Videos
    • Podcast & Media
    • Podcast Episodes
  • GMJ Articles
    • Vol. 1 Issue 3 (2026)
    • Public Health Dictionary — Supplement Edition
    • IAP Legacy Series
    • Read Full Journal (gmj.ge) →
    • Pre-Launch Articles (2025)
    • Vol. 1 Issue 1 (2026)
    • Vol. 1 Issue 2 (2026)
  • Perspectives
    • Editorial
    • Explainers
    • Letters
    • Voices
  • Policy & Systems
    • Global Health
    • Health Policy
    • Migration & Health
    • Quality & Safety
    • Work & Health
  • Dictionary
    • Our Story: 20 Years in the Making
    • Browse A–Z
    • About the Project
    • Contribute a Term
  • Practice
    • Case Discussions
    • Clinical Updates
    • Pharmacy & Prescribing
  • Research Digest
    • Data & Numbers
    • Georgian Research
    • New Studies
  • Read the Journal →
Follow US
GMJ News > GMJ Briefs > What Researchers Must Know: Protecting Critically Ill Patients in Clinical Studies

What Researchers Must Know: Protecting Critically Ill Patients in Clinical Studies

GMJ
Last updated: 24/06/2026 18:09
By
Prof. Giorgi Pkhakadze, MD, MPH, PhD
Share
1 Min Read
Illustration of research ethics framework for vulnerable patients
A new ethical and legal framework published in the Georgian Medical Journal clarifies that critically ill patients require independent ethical review and informed consent before research participation, with Georgian law fully aligning with international standards. — Photo: Engin Akyurt / Pexels
SHARE
1 min read|143 words

A new Georgian Medical Journal commentary provides critical guidance for researchers working with one of medicine’s most vulnerable populations. The analysis reveals three key insights: critically ill patients face heightened vulnerability due to cognitive impairment and therapeutic misconception; three ethical pillars—independent ethical review, informed consent, and risk–benefit assessment—are mandatory for all such research; and Georgia’s legal framework meets international standards for research protection.

For researchers and institutional review boards, this means that protecting critically ill participants requires rigorous adherence to ethical safeguards. The commentary clarifies that severe illness directly compromises decision-making capacity and can create dangerous power imbalances between patients and clinicians. By understanding these vulnerabilities and implementing the three-pillar framework, research institutions can conduct ethically sound studies while maintaining integrity and preventing exploitation of desperate patients who may overestimate experimental treatment benefits.

Read the full article on GMJ Newsroom.

Was this article helpful?

GMJ Brief · Takeaway

📰 Read the full article: New Framework Protects Critically Ill Patients in Clinical Research: International Standards Meet Georgian Law →

Share This Article
Facebook Whatsapp Whatsapp LinkedIn Telegram Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze, MD, MPH, PhD
Follow:
MD, MPH, PhD. Editor-in-Chief, Georgian Medical Journal (GMJ). Professor and Head, School of Public Health, David Tvildiani Medical University (DTMU), Tbilisi, Georgia. Chair, Public Health Institute of Georgia (PHIG). President, Accréditation Sans Frontières (ASF), Paris. Secretary/Treasurer, UEMS Section of Public Health. WHO Consultant, Health and Migration, Geneva. Former Member, UN Secretary-General's Independent Accountability Panel for Every Woman, Every Child, Every Adolescent (IAP-EWEC, 2016–2021). ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
L-Arginine’s Hidden Role: From Vascular Function to Alzheimer’s Protein Dynamics

L-arginine extends its biological influence far beyond vascular regulation into unexpected domains:…

Omega-3 Supplement Oxidation: Separating Controversy from Clinical Evidence

Omega-3 supplement oxidation is measurable in laboratories but clinical evidence of human…

Folic Acid Prevents Neural Tube Defects in 36% of Cases: Evidence Contradicts ‘Gene Test’ Claims

Folic acid supplementation has achieved a documented 36% reduction in neural tube…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Illustration of small-molecule drugs controlling genome editing tools for safer gene therapy

Takeaway: Small-Molecule Drugs Enable Safer, More Precise Therapeutic Genome Editing

By
Prof. Giorgi Pkhakadze, MD, MPH, PhD
28/06/2026
Global HealthHealth PolicyPolicy & Systems

COVID-19 Reshaped Outbreak Response: How Politics Now Shapes Public Health Decisions

By
Prof. Giorgi Pkhakadze, MD, MPH, PhD
23/07/2026
Scientific illustration of cell division failure showing tetraploid cells with doubled DNA content

What Clinicians Need to Know About Surviving Tetraploid Cells

By
Prof. Giorgi Pkhakadze, MD, MPH, PhD
27/06/2026
Illustration of insulin receptor with magnesium cofactor enabling glucose transporter activation

Meta-Analysis: Every 100 mg of Dietary Magnesium Cuts Type 2 Diabetes Risk by 14–19 Percent

By
Prof. Giorgi Pkhakadze, MD, MPH, PhD
31/07/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Accreditation Canada in Georgia
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?